Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Covers common skin issues in kids, their diagnosis, treatment, and need for specialist care.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Iron deficiency may contribute to hair loss.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.